BioengineeringbioRxivPreprint
Actinium-225 dendrimer-radioconjugates combined with low-dose standard-of-care chemotherapy: site-independent treatment of triple negative breast cancer metastases
Pooja Hariharan, Rajiv Nair, Aira Sarkar…·Stavroula Sofou
This study evaluates dendrimer-radioconjugates with Actinium-225 and low-dose cisplatin for treating metastatic triple negative breast cancer across different anatomical sites in mice, showing improved survival without long-term toxicity.
DOI 10.1101/2025.08.25.670941